Skip header and navigation

Refine By

   MORE

11 records – page 1 of 2.

[Antithrombin III level in patients with acute viral myocarditis]

https://arctichealth.org/en/permalink/ahliterature53507
Source
Lik Sprava. 2003 Apr-Jun;(3-4):63-5
Publication Type
Article
Author
B H Doroshenko
Source
Lik Sprava. 2003 Apr-Jun;(3-4):63-5
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adult
Anticoagulants - therapeutic use
Antithrombin III - metabolism
Blood Coagulation - drug effects
Diclofenac - therapeutic use
Drug Therapy, Combination
English Abstract
Heparin - therapeutic use
Humans
Myocarditis - blood - drug therapy - virology
Prednisolone - therapeutic use
Severity of Illness Index
Triazoles - therapeutic use
Virus Diseases - blood - drug therapy
Abstract
The article focuses on the status of a natural anticoagulant antithrombin III in patients with acute viral myocarditis (AVM) and on modes of treatment thereof. It has been proved that there is a statistically significant correlation between a drop in concentration of antithrombin III and degree of severity of AVM. Convincing, statistically significant data have been obtained that antithrombin III gets increased in AVM patients undergoing complex therapy: in those patients running a mild course of the illness, a mild one presenting with elevated indices for homeostasis, a medium gravity course (diclofenac, heparin, thiotriasoline, quick-frozen plasma), and grave course as well (prednizolon, heparin, thiotriasoline, quick-frozen plasma), which fact can be taken account of in choosing a therapeutic regimen.
PubMed ID
12889361 View in PubMed
Less detail

[Corticosteroid therapy of acute viral myocarditis in patients with severe clinical course of disease]

https://arctichealth.org/en/permalink/ahliterature53568
Source
Lik Sprava. 2002;(8):74-6
Publication Type
Article
Date
2002
Author
B H Doroshenko
P S Nazar
Source
Lik Sprava. 2002;(8):74-6
Date
2002
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adolescent
Adult
Anti-Inflammatory Agents - therapeutic use
Antibodies, Viral - analysis
Coxsackievirus Infections - drug therapy
English Abstract
Enterovirus B, Human - isolation & purification
Humans
Middle Aged
Myocarditis - drug therapy - virology
Prednisolone - therapeutic use
Severity of Illness Index
Abstract
The article is devoted to the issue of great current interest--that of treatment of patients with acute viral myocarditis. Topicality of the subject in touched upon in some detail, positive and negative sides of use of corticosteroids in patients with acute viral myocarditis are outlined. Comparative data are submitted of treatment of patients with acute viral myocarditis running a grave clinical course with heparin, thiotriasoline, complex heparin--thiotriasoline--prednisolone. The presented results of treatment show expediency of administration of corticosteroids leading to a statistically significant decrease in concentration of titres of antiviral antibodies Coxsackie B1-4 viruses, increase in ejection fraction, rises in platelet count in patients with acute viral myocarditis running a grave clinical course.
PubMed ID
12669549 View in PubMed
Less detail

[Fermental (plasmin) blood system in patients with acute viral myocarditis]

https://arctichealth.org/en/permalink/ahliterature98666
Source
Lik Sprava. 2009 Apr-Jun;(3-4):9-12
Publication Type
Article
Author
B H Doroshenko
M Iu Saliuta
P S Nazar
M D Kotko
O I Karpenko
S V Bezuhlova
Source
Lik Sprava. 2009 Apr-Jun;(3-4):9-12
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adolescent
Adult
Disseminated Intravascular Coagulation - blood - etiology - prevention & control
Female
Fibrinogen - analysis - metabolism
Fibrinolysin - analysis - metabolism
Fibrinolysis - drug effects
Humans
Male
Middle Aged
Myocarditis - blood - enzymology - virology
Severity of Illness Index
Virus Diseases - blood - enzymology
Young Adult
Abstract
For the first time it is established that patients with acute virus myocarditis (AVM) at all stages of severity of clinical course of the disease have changes in indicators of fibrinogens, soluble complexes of monomeric fibrin, products of its degradation, activated plasminogen, time recalcification of blood plasma to blood heparin, fibrinolytic activity of plasma, spontaneous fibrinolysis, time of lysis of euglobulin clot, blood heparin, antithrombin III, platelets. It testifies to suppression of fibrinolysis processes which expressiveness statistically reliably correlates with degree of severity of clinical course of AVM. Application of medicamentous correction is necessary for prevention of the development of disseminated intravascular blood coagulation syndrome.
PubMed ID
19957712 View in PubMed
Less detail

[Fibrinogen concentration status in patients with acute viral myocarditis]

https://arctichealth.org/en/permalink/ahliterature53458
Source
Lik Sprava. 2003 Jul-Aug;(5-6):28-30
Publication Type
Article
Author
B H Doroshenko
Source
Lik Sprava. 2003 Jul-Aug;(5-6):28-30
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adolescent
Adult
Anti-Inflammatory Agents - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Anticoagulants - therapeutic use
Comparative Study
Diclofenac - therapeutic use
English Abstract
Fibrinogen - analysis
Heparin - therapeutic use
Humans
Male
Middle Aged
Myocarditis - blood - drug therapy - virology
Prednisolone - therapeutic use
Severity of Illness Index
Triazoles - therapeutic use
Virus Diseases - blood - drug therapy
Abstract
The article is devoted to an urgent problem of the status of fibrinogen in patients with acute viral myocarditis and methods of the treatment. It is proved for the first time that a decrease in the concentration of fibrinogen as an indicator of thrombinemia correlates statistically to a great extent with the degree of severity of the condition in patients with acute viral myocarditis. Convincing, statistically significant data have been obtained on a decline in the concentration of fibrinogen in those patients with acute viral myocarditis placed on a complex therapy, running a mild course of the disease, a mild one presenting with elevated indices for hemostasis, and moderately severe course (diclofenac, heparin, thiotriazoline) as well, in grave condition (prednisolone, heparin, thiotriazoline), that can help in choosing of patient treatment tactics.
PubMed ID
14618797 View in PubMed
Less detail

[Hemostasis status in patients with acute viral myocarditis]

https://arctichealth.org/en/permalink/ahliterature53645
Source
Lik Sprava. 2002 Jul-Sep;(5-6):22-3
Publication Type
Article
Author
B H Doroshenko
Source
Lik Sprava. 2002 Jul-Sep;(5-6):22-3
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adolescent
Adult
English Abstract
Hemostasis
Humans
Middle Aged
Myocarditis - blood - virology
Severity of Illness Index
Abstract
Twelve percent of patients with a mild clinical course have been shown to be in the mild degree of severity of the clinical course by the clinical picture and state of the ejection fraction but by indices for hemostasis they approach moderately severe degree of the clinical course. Recognition of this fact makes the physician especially responsible for all he ventures in treating patients in the above group to prevent transformation into a more severe degree of the clinical course of acute viral myocarditis.
PubMed ID
12442512 View in PubMed
Less detail

[The blood coagulation aspects of acute infectious myocarditis]

https://arctichealth.org/en/permalink/ahliterature54375
Source
Lik Sprava. 1998 Mar-Apr;(2):40-3
Publication Type
Article
Author
B H Doroshenko
Source
Lik Sprava. 1998 Mar-Apr;(2):40-3
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adult
Blood Coagulation - drug effects
Blood Coagulation Tests - methods
Drug Therapy, Combination
English Abstract
Humans
Infection - blood - drug therapy
Myocarditis - blood - drug therapy
Abstract
Overall thirty-four patients with infectious myocarditis were studied by 9 coagulation techniques. A major proportion of this patient population displayed stage I blood disseminated intravascular coagulation syndrome. Treatment with coagulants, antiaggregants or nonsteroid antiinflammatory drugs resulted in positive dynamics of indices for coagulative and thrombovascular hemostasis, which observation significantly correlated with clinical improvement.
PubMed ID
9670651 View in PubMed
Less detail

[The drug correction of functional disorders of blood coagulation and lipid peroxidation in patients with infectious myocarditis]

https://arctichealth.org/en/permalink/ahliterature54257
Source
Lik Sprava. 1998 Dec;(8):3-6
Publication Type
Article
Date
Dec-1998
Author
B H Doroshenko
Source
Lik Sprava. 1998 Dec;(8):3-6
Date
Dec-1998
Language
Ukrainian
Publication Type
Article
Keywords
Blood Coagulation - drug effects
Cardiovascular Agents - therapeutic use
Communicable Diseases - blood - drug therapy - physiopathology
Disseminated Intravascular Coagulation - blood - drug therapy - physiopathology
Drug Therapy, Combination
English Abstract
Hemodynamic Processes - drug effects
Humans
Lipid Peroxidation - drug effects
Myocarditis - blood - drug therapy - physiopathology
Abstract
Carried out in this study for the first time was the diagnosis and treatment per groups of degree of severity of the clinical course of infectious myocarditis. According to the classification of the New York Association of Cardiology (1964, 1973), there has been established a clear correlation between the gravity of the process course, hemodialysis and cardiac haemodynamics.
PubMed ID
10204335 View in PubMed
Less detail

[The hemodynamic status of patients with infectious myocarditis]

https://arctichealth.org/en/permalink/ahliterature54198
Source
Lik Sprava. 1999 Jun;(4):102-5
Publication Type
Article
Date
Jun-1999
Author
P S Nazar
B H Doroshenko
Source
Lik Sprava. 1999 Jun;(4):102-5
Date
Jun-1999
Language
Ukrainian
Publication Type
Article
Keywords
Adult
Communicable Diseases - classification - drug therapy - physiopathology - ultrasonography
Echocardiography
English Abstract
Heart - physiopathology
Hemodynamic Processes - drug effects
Humans
Myocarditis - classification - drug therapy - physiopathology - ultrasonography
Abstract
Acute infectious myocarditis is accompanied by disturbances in the contractile function of the left ventricle, its degree being related to the gravity of the disease course. Improvement in the condition of the left ventricular contractile function correlates both with degree of severity of the illness and methodological approaches to the conducted therapy.
PubMed ID
10476656 View in PubMed
Less detail

[The leech therapy of infectious myocarditis]

https://arctichealth.org/en/permalink/ahliterature54312
Source
Lik Sprava. 1998 Aug;(6):146-8
Publication Type
Article
Date
Aug-1998
Author
P S Nazar
B H Doroshenko
Source
Lik Sprava. 1998 Aug;(6):146-8
Date
Aug-1998
Language
Ukrainian
Publication Type
Article
Keywords
Adolescent
Adult
Animals
Blood Coagulation
Bloodletting - methods
Communicable Diseases - blood - therapy
Comparative Study
English Abstract
Female
Humans
Leeches
Male
Middle Aged
Myocarditis - blood - therapy
Abstract
The novelty of the work consists in application of hirudotherapy (leeches) to treat infectious myocarditis, which therapy has been embarked on for the first time in the treatment of this medical condition. Coagulation methods used by the author are modern, the methodical approach is adequate. The role of hirudotherapy versus heparin therapy is shown.
PubMed ID
9844903 View in PubMed
Less detail

11 records – page 1 of 2.